A Pilot Study of Unsupervised Home-based Cardiac Rehabilitation Using a Wearable Device and Smartphone Application

A Pilot Study of Unsupervised Home-based Cardiac Rehabilitation Using a Wearable Device and Smartphone Application - A Pilot Study of Unsupervised Home-based Cardiac Rehabilitation with Gamification (GamiHeart pilot study)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000046777

Enrollment

Registered

2022-01-31

Start date

2022-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Cardiac Syndrome

Interventions

Wearing a smartwatch and using a smartphone application during the intervention period (4-5 weeks)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients hospitalized for acute coronary syndrome and undergoing percutaneous coronary intervention who are 20 years of age or older and can perform outdoor activities of daily living without assistance

Exclusion criteria

Exclusion criteria: 1. Patients who are unable to give their written consent 2. Patients who are unable to fill out the questionnaire on their own 3. Patients who are walking with a cane or cannot walk to the hospital by themselves 4. Patients with other serious diseases (cancer, collagen disease, etc.) who are judged by the physician in charge to be inappropriate for this study

Design outcomes

Primary

Measure	Time frame
Frequency with which patients appropriately performed unsupervised home-based cardiac rehabilitation during the study period	—

Secondary

Measure	Time frame
1. Change in body mass index, peak VO2 and anaerobic threshold in cardiopulmonary exercise test, LDL-cholesterol, HDL-cholesterol, triglycerides, and HbA1c in blood test 2. Change in Health-Related Quality of Life questionnaire (36-Item Short Form Survey, SF-36), depressive and anxiety symptoms questionnaire (Hospital Anxiety and Depression Scale, HADS) 3. Change in the visual analogue scale (0-100, with higher scores indicating greater discomfort with exercise therapy) (As for 1-3, changes are shown before and after the intervention period [4-5 weeks]). 4. Correlation between the results of the Type D personality questionnaire (Type D Scale-14, DS-14) administered before intervention and the primary outcome. 5. Frequency of new complications during the study period (4-5 weeks)	—

Measure

Time frame

1. Change in body mass index, peak VO2 and anaerobic threshold in cardiopulmonary exercise test, LDL-cholesterol, HDL-cholesterol, triglycerides, and HbA1c in blood test 2. Change in Health-Related Quality of Life questionnaire (36-Item Short Form Survey, SF-36), depressive and anxiety symptoms questionnaire (Hospital Anxiety and Depression Scale, HADS) 3. Change in the visual analogue scale (0-100, with higher scores indicating greater discomfort with exercise therapy) (As for 1-3, changes are shown before and after the intervention period [4-5 weeks]). 4. Correlation between the results of the Type D personality questionnaire (Type D Scale-14, DS-14) administered before intervention and the primary outcome. 5. Frequency of new complications during the study period (4-5 weeks)

—

Countries

Japan

Contacts

Public ContactToshiki Kaihara

St. Marianna University Hospital Cardiology

m03014tk@jichi.ac.jp044-977-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026